Work

Daratumumab (DARA) in Combination with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) in Patients with Newly Diagnosed Multiple Myeloma (MMY1001): Updated Results from an Open-Label, Phase 1b Study

Year: 2017

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.3110.3110

Authors: Ajai Chari, Saad Z. Usmani, Amrita Krishnan, Sagar Lonial, Raymond L. Comenzo, Kaida Wu, Jianping Wang, Parul Doshi, Brendan M. Weiss, Jordan M. Schecter, Andrzej Jakubowiak

Institutions: Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Carolinas Healthcare System, Levine Cancer Institute, City Of Hope National Medical Center, City of Hope, Emory University, Winship Cancer Institute, Tufts Medical Center, Janssen Research & Development (United States), Abramson Cancer Center, University of Pennsylvania, University of Chicago

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2912169683

FWCI: 3.8

Cites:

Cited by: 26

Related to: 20